# Business Requirement Document
## Clinical Trial Adverse Event Tracking System

### Project Overview

This document outlines the requirements for an internal application to automate adverse event tracking during clinical trials. The system will provide real-time monitoring, reporting, and analysis capabilities to ensure patient safety and regulatory compliance throughout the clinical trial process.

The Clinical Trial Adverse Event Tracking System (CT-AETS) will serve as a centralized platform for capturing, evaluating, and reporting adverse events that occur during pharmaceutical clinical trials. The system will integrate with existing Electronic Health Record (EHR) systems and provide comprehensive audit trails to maintain data integrity and regulatory compliance.

### Business Objectives

1. **Enhance Patient Safety**: Implement real-time adverse event monitoring to ensure rapid identification and response to potential safety issues during clinical trials.

2. **Regulatory Compliance**: Achieve and maintain compliance with FDA 21 CFR Part 11, HIPAA, and GxP requirements for electronic records and signatures.

3. **Operational Efficiency**: Reduce manual data entry and processing time by 70% through automation of adverse event capture and reporting workflows.

4. **Data Integrity**: Ensure complete audit trails and data validation to support regulatory inspections and internal quality audits.

5. **Stakeholder Communication**: Provide timely and accurate adverse event information to clinical investigators, sponsors, and regulatory authorities.

6. **Cost Reduction**: Minimize costs associated with manual adverse event management and regulatory non-compliance penalties.

### Functional Requirements

#### 1. Adverse Event Capture
- **FE-001**: System shall allow electronic capture of adverse events through web-based forms
- **FE-002**: System shall support integration with EHR systems for automatic adverse event detection
- **FE-003**: System shall provide standardized terminology for adverse event classification (MedDRA)
- **FE-004**: System shall enable attachment of supporting documents and evidence
- **FE-005**: System shall support multiple language input for global clinical trials

#### 2. Event Evaluation and Assessment
- **FE-006**: System shall provide automated severity assessment based on predefined criteria
- **FE-007**: System shall enable causality assessment between study drug and adverse events
- **FE-008**: System shall support workflow for medical review and validation
- **FE-009**: System shall provide decision support tools for event classification

#### 3. Reporting and Notifications
- **FE-010**: System shall generate regulatory-compliant adverse event reports (e.g., SAE reports)
- **FE-011**: System shall provide automated notifications to designated stakeholders
- **FE-012**: System shall support customizable report templates for different regulatory requirements
- **FE-013**: System shall enable electronic submission to regulatory authorities

#### 4. Data Management and Analytics
- **FE-014**: System shall maintain complete audit trails for all data modifications
- **FE-015**: System shall provide search and query capabilities for adverse event data
- **FE-016**: System shall generate statistical reports and trend analysis
- **FE-017**: System shall support data export in standard formats (CSV, XML)

### Non-Functional Requirements

#### 1. Performance Requirements
- **NFR-001**: System shall process adverse event submissions within 5 seconds
- **NFR-002**: System shall support concurrent access for 500+ users
- **NFR-003**: System shall maintain 99.9% uptime during clinical trial operations
- **NFR-004**: System shall complete report generation within 30 seconds

#### 2. Security Requirements
- **NFR-005**: System shall comply with HIPAA data protection requirements
- **NFR-006**: System shall implement role-based access control (RBAC)
- **NFR-007**: System shall encrypt all patient data in transit and at rest
- **NFR-008**: System shall maintain secure audit logs for all user activities

#### 3. Compliance Requirements
- **NFR-009**: System shall comply with FDA 21 CFR Part 11 for electronic records
- **NFR-010**: System shall support electronic signatures with proper authentication
- **NFR-011**: System shall maintain data integrity validation checks
- **NFR-012**: System shall support GxP validation and documentation requirements

#### 4. Usability Requirements
- **NFR-013**: System shall provide intuitive user interface requiring minimal training
- **NFR-014**: System shall support accessibility standards (WCAG 2.1)
- **NFR-015**: System shall provide context-sensitive help and documentation
- **NFR-016**: System shall support mobile device access for field users

### Key Performance Indicators (KPIs)

#### 1. Operational Metrics
- **KPI-001**: Average time from adverse event occurrence to system entry: <24 hours
- **KPI-002**: Percentage of events automatically detected from EHR: >80%
- **KPI-003**: Average time for regulatory report generation: <30 minutes
- **KPI-004**: System availability during clinical trial hours: >99.9%

#### 2. Quality Metrics
- **KPI-005**: Data accuracy rate for adverse event coding: >95%
- **KPI-006**: Percentage of events with complete documentation: >98%
- **KPI-007**: Audit trail completeness: 100%
- **KPI-008**: User satisfaction score: >8/10

#### 3. Compliance Metrics
- **KPI-009**: Regulatory submission timeliness: 100%
- **KPI-010**: Compliance audit pass rate: 100%
- **KPI-011**: Data integrity validation success rate: >99.5%
- **KPI-012**: Security incident count: 0 per quarter

### Compliance & Risk Assessment

#### Regulatory Compliance
- **FDA 21 CFR Part 11**: Electronic records and signatures, audit trails, system validation
- **HIPAA**: Patient data privacy, security safeguards, breach notification procedures
- **GxP**: Good Practice guidelines for pharmaceutical quality management
- **ICH Guidelines**: International Council for Harmonisation standards for clinical trials

#### Risk Assessment
- **High Risk**: Data breaches compromising patient privacy
- **Medium Risk**: System downtime affecting clinical trial operations
- **Medium Risk**: Incomplete adverse event reporting leading to regulatory penalties
- **Low Risk**: User adoption challenges affecting data quality

#### Mitigation Strategies
- Implement comprehensive security controls and regular security assessments
- Establish redundant systems and disaster recovery procedures
- Provide extensive user training and ongoing support
- Conduct regular compliance audits and system validations

### Stakeholder Analysis

#### Primary Stakeholders
- **Clinical Investigators**: Responsible for adverse event identification and reporting
- **Clinical Research Coordinators**: Manage day-to-day trial operations and data entry
- **Safety Officers**: Review and assess adverse events for severity and causality
- **Regulatory Affairs Teams**: Ensure compliance and manage regulatory submissions

#### Secondary Stakeholders
- **IT Department**: System maintenance and technical support
- **Quality Assurance**: System validation and compliance monitoring
- **Study Sponsors**: Oversight and funding for clinical trials
- **Regulatory Authorities**: FDA, EMA, and other regulatory bodies

#### Stakeholder Requirements
- Real-time access to adverse event data and reports
- Mobile accessibility for field-based clinical staff
- Integration with existing clinical trial management systems
- Comprehensive training and documentation

### Project Scope

#### Inclusions
- Adverse event capture and management system
- Integration with existing EHR systems
- Regulatory reporting capabilities
- Audit trail and compliance features
- User training and documentation
- System validation and testing

#### Exclusions
- Electronic Data Capture (EDC) system for clinical trial data
- Clinical trial management system (CTMS)
- Randomization and trial supply management
- Financial management and billing systems
- Patient recruitment and consent management

#### Assumptions
- Existing EHR systems can be integrated through standard APIs
- Clinical staff have basic computer literacy and can be trained
- Regulatory requirements will remain stable during implementation
- Sufficient network infrastructure exists to support system requirements

#### Constraints
- Must comply with all applicable pharmaceutical regulations
- Limited budget for custom development
- Timeline constraints driven by clinical trial schedules
- Integration limitations with legacy systems

---

**Document Version**: 1.0  
**Generated Date**: November 8, 2025  
**Domain**: Pharmaceutical  
**Compliance**: FDA 21 CFR Part 11, HIPAA, GxP  
**Validation Score**: 0.92/1.00